EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 25 / Numéro 8-9 (Août-Septembre 2009) Med Sci (Paris), 25 8-9 (2009) 733-738 Références
Numéro
Med Sci (Paris)
Volume 25, Numéro 8-9, Août-Septembre 2009
Accidents vasculaires cérébraux
Page(s) 733 - 738
Section M/S revues : Accidents vasculaires cérébraux (1)
DOI https://doi.org/10.1051/medsci/2009258-9733
Publié en ligne 15 août 2009
  1. Hankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999; 354 : 1457–63. [Google Scholar]
  2. Guidelines for management of ischaemic stroke and transient ischaemic attack. Cerebrovasc Dis 2008; 25 : 457–507. [Google Scholar]
  3. Langhorne P, Dennis MS. Stroke units, an evidence based approach. London : BMJ Publishing Group, 1998. [Google Scholar]
  4. Indredavik B, Bakke F, Slordahl SA, et al. Stroke unit treatment. 10-year follow-up. Stroke 1999; 30 : 1524–7. [Google Scholar]
  5. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363 : 768–74. [Google Scholar]
  6. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359 : 1317–29. [Google Scholar]
  7. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 2007; 369 : 275–82. [Google Scholar]
  8. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008; 372 : 1303–9. [Google Scholar]
  9. CAST. Randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese acute stroke trial) Collaborative Group. Lancet 1997; 349 : 1641–9. [Google Scholar]
  10. International-Stroke-Trial-Collaborative-Group. The International Stroke Trial (IST): a randomised trial if aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349 : 1569–81. [Google Scholar]
  11. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke 2000; 31 : 1770–8. [Google Scholar]
  12. Bath PM, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 2001; 358 : 702–10. [Google Scholar]
  13. Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 2000; 355 : 1205–10. [Google Scholar]
  14. Vahedi K, Hofmeijer J, Jüttler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 2007; 6 : 215–22. [Google Scholar]
  15. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7 : 391–9. [Google Scholar]
  16. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage. Part I: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis 2006; 22 : 294–316. [Google Scholar]
  17. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 2005; 365 : 387–97. [Google Scholar]
  18. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352 : 777–85. [Google Scholar]
  19. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008; 358 :2127–37. [Google Scholar]
  20. PROGRESS collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358 : 1033–41. [Google Scholar]
  21. Amarenco P, Bogousslavsky J, Callahan A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355 : 549–59. [Google Scholar]
  22. Algra A, van Gijn J. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin. J Neurol Neurosurg Psychiatry 1999; 66 : 255. [Google Scholar]
  23. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348 : 1329–39. [Google Scholar]
  24. Algra A. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial. Lancet Neurol 2007; 6 : 115–24. [Google Scholar]
  25. Sacco RL, Diener HC, Yusuf S, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 2008; 359 : 1238–51. [Google Scholar]
  26. Diener H, Bogousslavsky J, Brass L, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 2004; 364 : 331–7. [Google Scholar]
  27. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342 : 1255–62. [Google Scholar]
  28. The North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Engl J Med 1991; 325 : 445–53. [Google Scholar]
  29. The European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995; 345 : 209–12. [Google Scholar]
  30. Rothwell P, Eliasziw M, Gutnikov S, et al., for the Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363 : 915–24. [Google Scholar]
  31. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355 : 1660–71. [Google Scholar]
  32. Mas JL, Trinquart L, Leys D, et al. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol 2008; 7 : 885–92. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.